Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer.
Young Hyo ChoiJi Woong YuMin Yong KangHyun Hwan SungByong Chang JeongSeong Il SeoSeong Soo JeonHyun Moo LeeHwang Gyun JeonPublished in: World journal of urology (2019)
The combination of standard prostate biopsy and mpMRI did not accurately identify lobes that could be considered as non-treated regions.
Keyphrases
- prostate cancer
- ultrasound guided
- magnetic resonance imaging
- radical prostatectomy
- end stage renal disease
- newly diagnosed
- fine needle aspiration
- chronic kidney disease
- benign prostatic hyperplasia
- prognostic factors
- computed tomography
- magnetic resonance
- patient reported outcomes
- contrast enhanced
- diffusion weighted imaging